<DOC>
	<DOCNO>NCT01577706</DOCNO>
	<brief_summary>An advanced technique rapid magnetic resonance proton spectroscopic imaging ( 1H-MRSI ) employ drug challenge study healthy volunteer spatially map measure acute change brain chemical GABA , glutamate glutamine administration drug . Three condition test double-blind fashion , ) depressant , ii ) stimulant , iii ) placebo . It hypothesize unique reproducible spatial directional metabolic response pattern observe , unique condition within brain .</brief_summary>
	<brief_title>Spectroscopic Imaging 4T : A Drug Challenge Study</brief_title>
	<detailed_description>Proton magnetic resonance spectroscopy ( 1H MRS ) powerful tool assess neurochemistry non-invasively vivo . However , primary shortcoming study lack spatial coverage afford typical single-voxel design . Limits participant tolerance financial resource restrict single-voxel study examination one two carefully choose voxels per scan , thus inadequately address question focal vs. global pathophysiology . A secondary shortcoming study report either GABA glutamate-glutamine ( Glu-Gln ) due technically demand spectral-editing technique must implement order resolve quantify metabolite accuracy . 1H MRS imaging ( MRSI ) partially overcome limitation provide global picture brain chemistry rather focal snapshot afford single-voxel design . However , scan time necessary collect enough data adequate spatial resolution signal-to-noise , particularly also use specialize spectral-editing technique , still lengthy . We recently develop method combine Spectroscopic Imaging MEGAPRESS-based difference-editing acquisition optimal GABA detection well optimal detection Glu Gln . This MEGACSI sequence permit u obtain maximum amount neurochemical information clinically sound scan time , use current state-of-the-art MRS edit method optimal detection GABA , Glu , Gln .</detailed_description>
	<mesh_term>Dextroamphetamine</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Participants male volunteer age 2145 Nonsmoking participant prefer , admit smoke le 5 cigarette per day Participants must able read screen material include consent form give inform consent Participants meet DSMIV criterion lifetime and/or current mood , anxiety , psychotic , alcohol/drug use disorder identify SCID Participants take prescription medication ( except oral contraceptive , certain shortterm antifungal agent , topical cream dermal condition ) nutritional supplement Participants take psychotropic medication Participants history major head trauma result cognitive impairment , seizure , neurological disorder . Participants condition contraindicate MRI Participants family history alcoholism Participants abnormal blood chemistries/urinalysis result medical condition may affect drug disposition ( e.g. , Hepatitis C ) Participants current past cardiac problem , also family history sudden death ventricular arrhythmia Participants , investigator ' judgment , likely able comply study protocol . Participants clinically significant finding structural anatomic brain scan ( per MRI report read boardcertified radiologist ) .</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>GABA</keyword>
	<keyword>glutamate</keyword>
	<keyword>glutamine</keyword>
	<keyword>spectroscopy</keyword>
	<keyword>brain</keyword>
	<keyword>image</keyword>
	<keyword>alprazolam</keyword>
	<keyword>dextroamphetamine</keyword>
	<keyword>placebo</keyword>
</DOC>